100 related articles for article (PubMed ID: 15576971)
21. The teriparatide in the treatment of severe senile osteoporosis.
Manuele S; Sorbello L; Puglisi N; Grasso S; La Malfa L; D'Urbino G; Rizzotto M; Strano S; Maugeri D
Arch Gerontol Geriatr; 2007; 44 Suppl 1():249-58. PubMed ID: 17317460
[TBL] [Abstract][Full Text] [Related]
22. Osteoporotic fracture management in India: a survey of orthopaedic surgeons.
Lakhotia SM
J Indian Med Assoc; 2008 May; 106(5):318, 323-4. PubMed ID: 18839642
[TBL] [Abstract][Full Text] [Related]
23. Treatment of osteoporosis: combination therapies.
Simon JA; Mack CJ
Int J Fertil Womens Med; 2003; 48(3):127-31; discussion 137-8. PubMed ID: 12839144
[TBL] [Abstract][Full Text] [Related]
24. [Bisphosphonates and combined treatments osteoporosis].
Rizzoli R; Ferrari S
Rev Med Suisse; 2005 Oct; 1(35):2266, 2269-71. PubMed ID: 16268449
[TBL] [Abstract][Full Text] [Related]
25. A review of the literature on osteonecrosis of the jaw in patients with osteoporosis treated with oral bisphosphonates: prevalence, risk factors, and clinical characteristics.
Pazianas M; Miller P; Blumentals WA; Bernal M; Kothawala P
Clin Ther; 2007 Aug; 29(8):1548-58. PubMed ID: 17919538
[TBL] [Abstract][Full Text] [Related]
26. Patient treatment preferences for osteoporosis.
Fraenkel L; Gulanski B; Wittink D
Arthritis Rheum; 2006 Oct; 55(5):729-35. PubMed ID: 17013870
[TBL] [Abstract][Full Text] [Related]
27. Preventing osteoporotic fractures with bisphosphonates: a review of the efficacy and tolerability.
Masud T; Giannini S
Aging Clin Exp Res; 2003 Apr; 15(2):89-98. PubMed ID: 12889839
[TBL] [Abstract][Full Text] [Related]
28. Does the combination of alendronate and parathyroid hormone give a greater benefit than either agent alone in osteoporosis?
Doggrell SA
Expert Opin Pharmacother; 2004 Apr; 5(4):955-8. PubMed ID: 15102578
[TBL] [Abstract][Full Text] [Related]
29. When to use bisphosphonates.
Bachrach LK; Gandrud LM
J Pediatr; 2004 Feb; 144(2):285; author reply 285-6. PubMed ID: 14760281
[No Abstract] [Full Text] [Related]
30. Rationale for the use of alendronate in osteoporosis.
Kanis JA; Gertz BJ; Singer F; Ortolani S
Osteoporos Int; 1995 Jan; 5(1):1-13. PubMed ID: 7703618
[TBL] [Abstract][Full Text] [Related]
31. [Role of physician on the treatment of osteoporosis].
Shiraki M
Nihon Rinsho; 2003 Feb; 61(2):263-7. PubMed ID: 12638219
[TBL] [Abstract][Full Text] [Related]
32. Antagonizing the calcium-sensing receptor: towards new bone anabolics?
Riccardi D
Curr Mol Pharmacol; 2012 Jun; 5(2):182-8. PubMed ID: 21787287
[TBL] [Abstract][Full Text] [Related]
33. [Space flight/bedrest immobilization and bone. Medical treatment for immobilization osteoporosis].
Kinoshita Y; Fukumoto S
Clin Calcium; 2012 Dec; 22(12):1895-901. PubMed ID: 23187083
[TBL] [Abstract][Full Text] [Related]
34. Bifunctional bisphosphonates for delivering PTH (1-34) to bone mineral with enhanced bioactivity.
Yewle JN; Puleo DA; Bachas LG
Biomaterials; 2013 Apr; 34(12):3141-9. PubMed ID: 23369219
[TBL] [Abstract][Full Text] [Related]
35. Combination therapy for osteoporosis: considerations and controversy.
Binkley N; Krueger D
Curr Rheumatol Rep; 2005 Mar; 7(1):61-5. PubMed ID: 15760582
[TBL] [Abstract][Full Text] [Related]
36. Differences between the bisphosphonates for the prevention and treatment of osteoporosis.
Grey A; Reid IR
Ther Clin Risk Manag; 2006 Mar; 2(1):77-86. PubMed ID: 18360583
[TBL] [Abstract][Full Text] [Related]
37. [Influence of the different bisphosphonates dose regimens on its tolerability].
Sosa Henríquez M; Gómez de Tejada Romero MJ
An Med Interna; 2006 Dec; 23(12):596-601. PubMed ID: 17371151
[TBL] [Abstract][Full Text] [Related]
38. New bisphosphonates for the treatment of osteoporosis: concerns and hopes.
Reginster JY
Rev Rhum Engl Ed; 1996; 63(7-8):461-4. PubMed ID: 8896057
[No Abstract] [Full Text] [Related]
39. Effect of pharmacological treatment of osteoporosis in the prevention of pathological vertebral fractures.
Pellegrino P; Carnovale C; Perrone V; Pozzi M; Salvati D; Gentili M; Brusadelli T; Antoniazzi S; Radice S; Clementi E
Bone; 2014 Feb; 59():148-9. PubMed ID: 24239754
[No Abstract] [Full Text] [Related]
40. A new option for osteoporosis.
Johns Hopkins Med Lett Health After 50; 2005 Jul; 17(5):7. PubMed ID: 16138408
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
